These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7872845)

  • 1. Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come.
    Meltzer HY
    Arch Gen Psychiatry; 1995 Mar; 52(3):200-2. PubMed ID: 7872845
    [No Abstract]   [Full Text] [Related]  

  • 2. Why neuroleptic withdrawal in schizophrenia?
    Carpenter WT; Tamminga CA
    Arch Gen Psychiatry; 1995 Mar; 52(3):192-3. PubMed ID: 7872843
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuroleptic withdrawal in schizophrenic patients.
    Baldessarini RJ; Viguera AC
    Arch Gen Psychiatry; 1995 Mar; 52(3):189-92. PubMed ID: 7872842
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term treatment for lifetime disorders?
    Greden JF; Tandon R
    Arch Gen Psychiatry; 1995 Mar; 52(3):197-200. PubMed ID: 7872844
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic withdrawal in schizophrenic patients. A review of the literature.
    Gilbert PL; Harris MJ; McAdams LA; Jeste DV
    Arch Gen Psychiatry; 1995 Mar; 52(3):173-88. PubMed ID: 7872841
    [No Abstract]   [Full Text] [Related]  

  • 6. The early course of schizophrenia and long-term maintenance neuroleptic therapy.
    Nuechterlein KH; Gitlin MJ; Subotnik KL
    Arch Gen Psychiatry; 1995 Mar; 52(3):203-5. PubMed ID: 7872846
    [No Abstract]   [Full Text] [Related]  

  • 7. Risks of withdrawing antipsychotic medications.
    Wyatt RJ
    Arch Gen Psychiatry; 1995 Mar; 52(3):205-8. PubMed ID: 7872847
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychotic recurrence after antipsychotic discontinuation.
    Zipursky RB
    Am J Psychiatry; 2002 Aug; 159(8):1441-2; author reply 1442. PubMed ID: 12153856
    [No Abstract]   [Full Text] [Related]  

  • 9. Considering neuroleptic maintenance and taper on a continuum. Need for individual rather than dogmatic approach.
    Jeste DV; Gilbert PL; McAdams LA; Harris MJ
    Arch Gen Psychiatry; 1995 Mar; 52(3):209-12. PubMed ID: 7872848
    [No Abstract]   [Full Text] [Related]  

  • 10. Medication-free minors with schizophrenia.
    Cohen D
    Am J Psychiatry; 2001 Feb; 158(2):324. PubMed ID: 11156827
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment.
    Viguera AC; Baldessarini RJ; Hegarty JD; van Kammen DP; Tohen M
    Arch Gen Psychiatry; 1997 Jan; 54(1):49-55. PubMed ID: 9006400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal.
    Llorca PM; Vaiva G; Lancon C
    Can J Psychiatry; 2001 Feb; 46(1):87-8. PubMed ID: 11221497
    [No Abstract]   [Full Text] [Related]  

  • 13. Supersensitivity psychosis.
    Peet M
    J Clin Psychiatry; 1991 Feb; 52(2):90. PubMed ID: 1671568
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
    Singh H; Hunt JI; Vitiello B; Simpson GM
    J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The concept of supersensitivity psychosis.
    Kirkpatrick B; Alphs L; Buchanan RW
    J Nerv Ment Dis; 1992 Apr; 180(4):265-70. PubMed ID: 1348269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic-free intervals in the treatment of schizophrenia.
    Pyke J; Seeman MV
    Am J Psychiatry; 1981 Dec; 138(12):1620-1. PubMed ID: 6118068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation.
    Dickson R; Williams R; Dalby JT
    Can J Psychiatry; 1994 Apr; 39(3):184. PubMed ID: 7518338
    [No Abstract]   [Full Text] [Related]  

  • 18. Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs.
    Kristjansen P
    Adv Biochem Psychopharmacol; 1980; 24():505-11. PubMed ID: 6105796
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe extrapyramidal side effects when discontinuing clozapine and starting haloperidol.
    Bobba R
    Can J Psychiatry; 1997 Jun; 42(5):530. PubMed ID: 9220119
    [No Abstract]   [Full Text] [Related]  

  • 20. Switching patients from clozapine to risperidone therapy.
    Zimbroff DL
    Am J Psychiatry; 1995 Jul; 152(7):1102. PubMed ID: 7540802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.